These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The phosphotidyl inositol 3-kinase/Akt signal pathway is involved in interleukin-6-mediated Mcl-1 upregulation and anti-apoptosis activity in basal cell carcinoma cells. Jee SH, Chiu HC, Tsai TF, Tsai WL, Liao YH, Chu CY, Kuo ML. J Invest Dermatol; 2002 Nov; 119(5):1121-7. PubMed ID: 12445202 [Abstract] [Full Text] [Related]
6. Interleukin-6 acts as an antiapoptotic factor in human esophageal carcinoma cells through the activation of both STAT3 and mitogen-activated protein kinase pathways. Leu CM, Wong FH, Chang C, Huang SF, Hu CP. Oncogene; 2003 Oct 30; 22(49):7809-18. PubMed ID: 14586407 [Abstract] [Full Text] [Related]
7. IL-6 up-regulates mcl-1 in human myeloma cells through JAK / STAT rather than ras / MAP kinase pathway. Puthier D, Bataille R, Amiot M. Eur J Immunol; 1999 Dec 30; 29(12):3945-50. PubMed ID: 10602002 [Abstract] [Full Text] [Related]
14. Activation of sphingosine kinase mediates suppressive effect of interleukin-6 on human multiple myeloma cell apoptosis. Li QF, Wu CT, Duan HF, Sun HY, Wang H, Lu ZZ, Zhang QW, Liu HJ, Wang LS. Br J Haematol; 2007 Sep 30; 138(5):632-9. PubMed ID: 17686057 [Abstract] [Full Text] [Related]